Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast Phase 2b in Plaque Psoriasis
NCT00773734Phase 2Completed
- Sponsor
- Amgen
- Start
- Sep 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started Sep 2008; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00773734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773734.